A first-of-its-kind sensor that sticks to the throat and measures speech and swallowing patterns could be a game-changer in the field of stroke rehabilitation.
A comprehensive evaluation by clinical researchers at the Perelman School of Medicine at the University of Pennsylvania identified a neurological syndrome that left US government personnel serving in Havana, Cuba with persistent memory and thinking dysfunction, as well as vision and balance problems after hearing unusual noises in their homes or hotel rooms. The team published their findings in JAMA.
A study from scientists at The Scripps Research Institute (TSRI) explains why the risk of osteoarthritis increases as we age and offers a potential avenue for developing new therapies to maintain healthy joints.
New research published in the Journal of Physiology could open the door to new therapies to improve the movement of arms and hands of stroke survivors.
Many parents of children with disabilities don't make advance care plans in the event of the parent's or other caretaker's death or disability, according to a new nationwide survey by special education professor Meghan Burke at the University of Illinois.
A Japanese research group has successfully grafted human iPS cell-derived inner ear cells that express human-derived proteins into the inner ears of embryonic mice. Hereditary hearing loss accounts for about half of all congenital hearing loss cases, and this work is a major contribution toward research that targets the embryonic inner ear.
Few research efforts have focused on interventions for adults, but a new six-year collaborative trial tested two treatments for adults with autism -- and found strong, but different, results.
A new algorithm developed at the University of Waterloo will help first responders and home care providers better help the elderly during natural disasters.
Disabled children in West Africa experience significantly greater violence than their non-disabled peers and all experience violence from they day they are born, finds a study published in BMC Public Health by Janet Njelesani, assistant professor of occupational therapy at New York University Steinhardt School of Culture, Education, and Human Development.
An experimental therapy that targets the spinal cord may one day be key to spurring on enhanced recovery for stroke victims. By injecting a drug called chondroitinase ABC (ChABC) into the spinal cord of rats 28 days after they suffered a stroke, UAlberta researchers found they were able to enhance recovery by inducing amplified rewiring of circuits connecting the brain to the spinal cord. When they also combined the spinal therapy with rehabilitative training, recovery amplified further.